AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.670
-0.210 (-7.29%)
Apr 17, 2026, 4:08 PM HKT

AIM Vaccine Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1661,2851,1871,2641,570
Revenue Growth (YoY)
-9.29%8.22%-6.06%-19.49%-4.14%
Cost of Revenue
405.47331.521,799236.41275.43
Gross Profit
760.2953.51-611.211,0281,295
Selling, General & Admin
783.81825.4748.29943.921,628
Research & Development
191.28363.13636.4500.31307.35
Operating Expenses
968.081,1821,3891,4711,943
Operating Income
-207.87-228.76-2,000-443.79-648.73
Interest Expense
-57.84-60.8-43.83-25.69-10.7
Interest & Investment Income
3.437.4910.7110.6910.78
Currency Exchange Gain (Loss)
2.67-0.66-2.03
Other Non Operating Income (Expenses)
18.8224.0927.5221.5538.25
EBT Excluding Unusual Items
-240.79-257.97-2,005-437.24-608.38
Impairment of Goodwill
---211.44--
Gain (Loss) on Sale of Investments
---3.071.67
Gain (Loss) on Sale of Assets
--6.92--
Asset Writedown
-525.77-32.75-61.09--
Pretax Income
-766.56-290.72-2,271-434.17-606.7
Income Tax Expense
-22.83-12.25-320.4-203.5469.17
Earnings From Continuing Operations
-743.73-278.47-1,950-230.63-675.87
Minority Interest in Earnings
68.271.24649.24-88.97-16.9
Net Income
-675.46-277.23-1,301-319.6-692.77
Net Income to Common
-675.46-277.23-1,301-319.6-692.77
Shares Outstanding (Basic)
1,2241,2111,2111,2031,163
Shares Outstanding (Diluted)
1,2241,2111,2111,2031,163
Shares Change (YoY)
1.05%-0.71%3.44%20.78%
EPS (Basic)
-0.55-0.23-1.07-0.27-0.60
EPS (Diluted)
-0.55-0.23-1.07-0.27-0.60
Free Cash Flow
--22.56-324.42-889.33-1,032
Free Cash Flow Per Share
--0.02-0.27-0.74-0.89
Gross Margin
65.22%74.20%-51.47%81.30%82.46%
Operating Margin
-17.83%-17.80%-168.43%-35.11%-41.32%
Profit Margin
-57.95%-21.57%-109.56%-25.28%-44.12%
Free Cash Flow Margin
--1.75%-27.32%-70.35%-65.73%
EBITDA
-76.78-97.67-1,859-307.38-529.57
EBITDA Margin
-6.59%-7.60%-156.53%-24.32%-33.73%
D&A For EBITDA
131.09131.09141.38136.41119.16
EBIT
-207.87-228.76-2,000-443.79-648.73
EBIT Margin
-17.83%-17.80%-168.43%-35.11%-41.32%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.